This trial is completed!
Search for a recruiting clinical trial for your condition
Your journey
1What's a trial
4Get in touch
More info
You can access this
clinical trial
if you have
Seasonal Allergic Rhinitis
and you are
between 6 and 11
years old
This is a trial in the final phase before the treatment is released on the market.
Show me locations

The purpose

This is a 2-week, multicenter, randomized, double-blind, placebo-controlled, parallel group, efficacy and safety study of ciclesonide nasal aerosol administered once daily to male and premenarchal female subjects 6 to 11 years-old diagnosed with SAR.

Provided treatments

  • Drug: Ciclesonide nasal aerosol 37 mcg
  • Drug: ciclesonide nasal aerosol 74 mcg
  • Drug: Placebo

Locations near you

Unfortunately, there are no recruiting locations near you. Please check the list with all locations below.
Tris trial is registered with FDA with number: NCT01458275. The sponsor of the trial is Sunovion and it is looking for 847 volunteers for the current phase.
Official trial title:
A 2-Week Randomized, Double-Blind, Placebo-Controlled, Parallel Group, Safety and Efficacy Study of Ciclesonide Nasal Aerosol in Subjects 6 to 11 Years With Seasonal Allergic Rhinitis